BIOLASE, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BIOL research report →
About the company
BIOLASE, Inc. , along with its various divisions, operates as a global enterprise specializing in the creation, production, distribution, and sale of advanced laser systems. These technologies are specifically designed for dental professionals and their patients across the United States and internationally.
- CEO
- John R. Beaver
- IPO
- 1992
- Employees
- 157
- HQ
- Foothill Ranch, CA, US
Price Chart
- Market Cap
- $731.94K
- P/E
- -0.00
- P/S
- 0.01
- P/B
- -0.10
- EV/EBITDA
- -0.78
- Div Yield
- 0.00%
- Gross Margin
- 34.02%
- Op Margin
- -36.48%
- Net Margin
- -41.97%
- ROE
- -888.93%
- ROIC
- -96.48%
- Revenue
- $49.16M · 1.45%
- Net Income
- $-20,632,000 · 27.95%
- EPS
- $-16.14 · 96.09%
- Op Income
- $-17,937,000
- FCF YoY
- 49.48%
- 52W High
- $1.94
- 52W Low
- $0.02
- 50D MA
- $0.06
- 200D MA
- $0.28
- Beta
- 0.68
- Avg Volume
- 201.37K
Get TickerSpark's AI analysis on BIOL
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 28, 23 | GOLDMAN SACHS GROUP INC | other | 0 |
| Jun 8, 23 | Yale Kenneth P. | other | 502,404 |
| Jun 8, 23 | Somerman Martha J. DDS, PhD | other | 518,429 |
| Jun 8, 23 | ROPER JESS | other | 512,821 |
| Jun 8, 23 | OLoughlin Kathleen T | other | 502,404 |
| Jun 8, 23 | Summerhays Carol Gomez DDS | other | 491,987 |
| Jun 8, 23 | LORD JONATHAN T MD | other | 721,154 |
| Jun 2, 23 | Sandor Steven | other | 58,000 |
| Jun 2, 23 | Bright Jennifer | other | 58,000 |
| Jun 2, 23 | BEAVER JOHN R | other | 486,255 |
Our BIOL coverage
Recent articles, reports, and earnings notes.
No research on BIOL yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BIOL report →Similar companies
Peers in the same neighborhood.